Day 2. Session 9: Is liver transplantation for hepatocellular carcinoma macrovascular invasion justified? PRO

This content is only available to Web Visitors and ILTS members. Please sign up for a free Web Visitor account to view this content.

Sorry, you don't have access to this lecture!

This content is only available to Web Visitors and ILTS members. Please sign up for a free Web Visitor account to view this content.

Topics

Meeting

• ILS Week 2021

Speakers

• Christian Toso

• Day 2. Session 8: Live Donor steatosis reduction and outcome

  This content is only available to Web Visitors and ILTS members. Please sign up for...
• Day 2. Session 9: Is liver transplantation for hepatocellular carcinoma macrovascular invasion justified? CON

  This content is only available to Web Visitors and ILTS members. Please sign up for...
• Day 1. Session 3: Incidence, Risk Factors and Outcomes for Alcohol Recidivism after Liver Transplantation

  This content is only available to Web Visitors and ILTS members. Please sign up for...

• Risk of hepatocellular carcinoma: surveillance and management

  For ILTS members only, please join now or renew your membership.
• Are there upper limits in tumor burden for downstaging of HCC to Liver? No.

  For ILTS members only, please join now or renew your membership.
• Liver transplantation for malignancies: LT for HCC – modelling the criteria

  For ILTS members only, please join now or renew your membership.